Lyra stockholders approve officer exculpation amendment and elect two Class I directors

Lyra Therapeutics, Inc.

Officer exculpation amendment approved: 38.8M for, 1.2M against, 8k abstain.
Class I directors elected: Poukalov (38.6M for) and Snyderman (33.4M for).
BDO USA ratified as auditor for FY2024: 47.5M for, 47.7k against.

item 5.03 item 5.07 item 9.01

Lyra Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-163395

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.